GOOGL   1,423.51 (+0.37%)
AMZN   2,411.53 (+0.43%)
CGC   17.44 (-19.71%)
BABA   199.59 (+0.05%)
MU   46.34 (-0.28%)
GE   6.55 (-3.39%)
TSLA   807.16 (+0.17%)
AMD   51.74 (+0.00%)
GILD   75.42 (+0.13%)
DIS   116.02 (-0.63%)
GOOGL   1,423.51 (+0.37%)
AMZN   2,411.53 (+0.43%)
CGC   17.44 (-19.71%)
BABA   199.59 (+0.05%)
MU   46.34 (-0.28%)
GE   6.55 (-3.39%)
TSLA   807.16 (+0.17%)
AMD   51.74 (+0.00%)
GILD   75.42 (+0.13%)
DIS   116.02 (-0.63%)
GOOGL   1,423.51 (+0.37%)
AMZN   2,411.53 (+0.43%)
CGC   17.44 (-19.71%)
BABA   199.59 (+0.05%)
MU   46.34 (-0.28%)
GE   6.55 (-3.39%)
TSLA   807.16 (+0.17%)
AMD   51.74 (+0.00%)
GILD   75.42 (+0.13%)
DIS   116.02 (-0.63%)
GOOGL   1,423.51 (+0.37%)
AMZN   2,411.53 (+0.43%)
CGC   17.44 (-19.71%)
BABA   199.59 (+0.05%)
MU   46.34 (-0.28%)
GE   6.55 (-3.39%)
TSLA   807.16 (+0.17%)
AMD   51.74 (+0.00%)
GILD   75.42 (+0.13%)
DIS   116.02 (-0.63%)
Log in

NYSEAMERICAN:SENSSenseonics Stock Price, Forecast & News

$0.48
-0.02 (-4.00 %)
(As of 05/29/2020 09:00 AM ET)
Add
Compare
Today's Range
$0.48
Now: $0.48
$0.51
50-Day Range
$0.97
MA: $1.07
$1.17
52-Week Range
$0.45
Now: $0.48
$2.24
Volume2.32 million shs
Average Volume2.33 million shs
Market Capitalization$107.11 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Read More
Senseonics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.9Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:SENS
Previous SymbolNASDAQ:SENS
CUSIPN/A
CIKN/A
Phone+1-301-5157260

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees191
Market Cap$107.11 million
Next Earnings DateN/A
OptionableOptionable

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

Senseonics (NYSEAMERICAN:SENS) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Senseonics?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Senseonics.

How were Senseonics' earnings last quarter?

Senseonics Holdings Inc (NYSEAMERICAN:SENS) issued its earnings results on Thursday, March, 12th. The company reported ($0.18) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.16) by $0.02. The business earned $9 million during the quarter, compared to analyst estimates of $7.93 million. View Senseonics' earnings history.

What guidance has Senseonics issued on next quarter's earnings?

Senseonics updated its FY 2020 After-Hours earnings guidance on Thursday, March, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $15-20 million, compared to the consensus revenue estimate of $36.29 million.

What price target have analysts set for SENS?

8 Wall Street analysts have issued twelve-month price objectives for Senseonics' shares. Their forecasts range from $0.25 to $2.00. On average, they anticipate Senseonics' share price to reach $1.23 in the next twelve months. This suggests a possible upside of 156.9% from the stock's current price. View analysts' price targets for Senseonics.

Has Senseonics been receiving favorable news coverage?

News headlines about SENS stock have been trending somewhat positive on Friday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Senseonics earned a news sentiment score of 0.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the company's share price in the near term. View the latest news aboutSenseonics.

Who are some of Senseonics' key competitors?

What other stocks do shareholders of Senseonics own?

Who are Senseonics' key executives?

Senseonics' management team includes the following people:
  • Dr. Timothy T. Goodnow, Pres, CEO & Director (Age 58, Pay $897.8k)
  • Dr. Mukul Jain, Chief Operating Officer (Age 47, Pay $572.75k)
  • Mr. Nick B. Tressler, Chief Financial Officer (Age 47)
  • Dr. Francine Ratner Kaufman, Chief Medical Officer & Director (Age 69)

What is Senseonics' stock symbol?

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Who are Senseonics' major shareholders?

Senseonics' stock is owned by many different institutional and retail investors. Top institutional shareholders include NEA Management Company LLC (13.71%), BlackRock Inc. (4.38%), State Street Corp (0.91%), Geode Capital Management LLC (0.82%), Raymond James Financial Services Advisors Inc. (0.28%) and Nuveen Asset Management LLC (0.24%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain and Timothy T Goodnow. View institutional ownership trends for Senseonics.

Which institutional investors are selling Senseonics stock?

SENS stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Morgan Stanley, UBS Group AG, BlackRock Inc., Spark Investment Management LLC, Raymond James Financial Services Advisors Inc., and Rhumbline Advisers. View insider buying and selling activity for Senseonics.

Which institutional investors are buying Senseonics stock?

SENS stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Beacon Pointe Advisors LLC, Geode Capital Management LLC, Squarepoint Ops LLC, Alliancebernstein L.P., Advisor Group Holdings Inc., Wells Fargo & Company MN, and Palisades Hudson Asset Management L.P.. View insider buying and selling activity for Senseonics.

How do I buy shares of Senseonics?

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Senseonics' stock price today?

One share of SENS stock can currently be purchased for approximately $0.48.

How big of a company is Senseonics?

Senseonics has a market capitalization of $107.11 million. Senseonics employs 191 workers across the globe.

What is Senseonics' official website?

The official website for Senseonics is www.senseonics.com.

How can I contact Senseonics?

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.